UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: CBZEssPharm-250mg-Supp-SE-AJ-MPD

Generated Narrative: MedicinalProductDefinition CBZEssPharm-250mg-Supp-SE-AJ-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100013348-00011830, http://ema.europa.eu/fhir/eurdId/539

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Suppository

indication:

Epilepsier. Generaliserade toniska-kloniska anfall (grand mal). Partiella anfall. Karbamazepin är ej verksamt vid absenser (petit mal).

legalStatusOfSupply: Medicinal product subject to medical prescription

classification: carbamazepine

name

productName: Carbamazepine Essential Pharma 250 mg Suppositorium

part

part: Name

type: Scientific Name Part

part

part: 250 mg

type: Strength part

part

part: Suppositorium

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish